PC-786: Clinical Trials

2 trials of PC-786, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 21Completed 1

Follow PC-786: new trials by email Literature Review of PC-786 trials Research Report on PC-786

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of PC786 to Evaluate the Antiviral Activity, Safety and Pharmacokinetics of Multiple Doses in an RSV Challenge Study
PC786, Placebo/vehicle - Respiratory Syncytial Virus Infections
Phase 1 / Phase 2CompletedPulmocide Ltd562017-11-142018-05-16
A Study to Investigate the Safety and Tolerability of Single and Repeat Doses of PC786
PC786 - Single doses, Placebo - Single doses, PC786 - Repeat doses - Respiratory Syncytial Virus (RSV)
Phase 1CompletedPulmocide Ltd392017-06-212017-12-21

Conditions studied

Respiratory Syncytial Virus Infections (1)

Sponsors

Pulmocide Ltd (2)

Countries

United Kingdom (2)

Top investigators

Bryan J Murray, MBBS (1)  ·  Malcolm J Boyce, MBChB, MD (1)

Results publications

PMID 33216113

NIH funding

2016 (1), 2017 (1)